Wednesday, July 8, 2026

pharma · Malaria · Pharmacokinetics · CNSP

CNS Pharmaceuticals

CNS Pharmaceuticals patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Houston, TX 77027, US HQ
2017 Founded
12 Employees
Public company Type
CNSP · NYSE Ticker
Company details
Status
Public
HQ
Houston, TX 77027, US
Founded
2017
Employees
12
Programs
21
Drugs
18
Patents
0
Intelligence · Patents

CNS Pharmaceuticals patents

0 pharmaceutical patents indexed for CNS Pharmaceuticals. 0 expire within 24 months.

CNS Pharmaceuticals has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

No patents matched

Try a different expiry filter or check back as we index more USPTO records.

Frequently asked questions

How many patents does CNS Pharmaceuticals have?

0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do CNS Pharmaceuticals patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.